Linkedin

Home
Startup Insight
Stories
Articles
Features

Sign in

Welcome!Log into your account

your username

your password

Forgot your password?

Password recovery

Recover your password

your email

Search

Home Tags F-Prime Capital

F-Prime Capital

OnCusp Therapeutics, Inc., a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide, today announced an oversubscribed $100 million Series A financing round.

[Funding alert]OnCusp Therapeutics Raises Oversubscribed $100 Mn Series A Financing

Startuprise io - January 5, 2024

ABOUT US

Startup Rise - USA is rapidly growing business media platform for entrepreneurs and startups to cover and publish their journeys through Video Talks, Interviews, Articles and News.

Contact us: contact@startuprise.io

FOLLOW US

© Copyright Startup Rise USA 2025 All Rights Reserved.

Newsletter

Subscribe to our weekly newsletter and don't forget to check out the latest updates.

EmailEnter your email address

Thanks, I’m not interested